Literature DB >> 16499542

Changes in newspaper coverage about hormone therapy with the release of new medical evidence.

Jennifer S Haas1, Berta Geller, Diana L Miglioretti, Diana S M Buist, David E Nelson, Karla Kerlikowske, Patricia A Carney, Erica S Breslau, Sarah Dash, Mary K Canales, Rachel Ballard-Barbash.   

Abstract

BACKGROUND: Results of 2 trials of postmenopausal hormone therapy (HT) challenged established practice patterns; 1 was not associated with changes in HT use, whereas the other was associated with substantial decline. Differential coverage by lay newspapers may have contributed to the differential impact.
OBJECTIVE: To examine newspaper coverage of HT before and after the publication of the Heart and Estrogen Replacement Study (HERS) in August 1998, and the main findings of the estrogen plus progestin therapy arm of the Women's Health Initiative (EPT-WHI) in July 2002.
DESIGN: Longitudinal review of newspaper articles, 1998 to 2003 (n=663).
SETTING: Twenty local and 6 regional/national newspapers. MEASUREMENTS: Number and content of articles about HT.
RESULTS: The average number of articles about HT published during the month of the publication of the EPT-WHI was at least 8-fold greater than the number of articles published on the topic during any prior period. While the majority of articles in all periods presented information about the potential benefits of HT, information about harms became more common than information about benefits during the 2 months before the publication of the EPT-WHI, when the trial participants were notified of the early termination of the study. The presentation of specific health harms was more common after the publication of the EPT-WHI than after the publication of HERS. Few articles in any period used visual aids.
CONCLUSIONS: The publication of the EPT-WHI was associated with a change in both the volume and content of newspaper coverage about HT.

Entities:  

Mesh:

Year:  2006        PMID: 16499542      PMCID: PMC1484740          DOI: 10.1111/j.1525-1497.2006.00342.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  24 in total

1.  Coverage by the news media of the benefits and risks of medications.

Authors:  R Moynihan; L Bero; D Ross-Degnan; D Henry; K Lee; J Watkins; C Mah; S B Soumerai
Journal:  N Engl J Med       Date:  2000-06-01       Impact factor: 91.245

2.  Newspaper reporting of screening mammography.

Authors:  J Wells; P Marshall; B Crawley; K Dickersin
Journal:  Ann Intern Med       Date:  2001-12-18       Impact factor: 25.391

Review 3.  Explaining risks: turning numerical data into meaningful pictures.

Authors:  Adrian Edwards; Glyn Elwyn; Al Mulley
Journal:  BMJ       Date:  2002-04-06

4.  Press releases: translating research into news.

Authors:  Steven Woloshin; Lisa M Schwartz
Journal:  JAMA       Date:  2002-06-05       Impact factor: 56.272

5.  Media coverage of scientific meetings: too much, too soon?

Authors:  Lisa M Schwartz; Steven Woloshin; Linda Baczek
Journal:  JAMA       Date:  2002-06-05       Impact factor: 56.272

6.  Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.

Authors:  Alan Cassels; Merrilee A Hughes; Carol Cole; Barbara Mintzes; Joel Lexchin; James P McCormack
Journal:  CMAJ       Date:  2003-04-29       Impact factor: 8.262

7.  News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer.

Authors:  Lisa M Schwartz; Steven Woloshin
Journal:  JAMA       Date:  2002-06-19       Impact factor: 56.272

8.  On the prevention and treatment of exaggeration.

Authors:  Lisa M Schwartz; Steven Woloshin
Journal:  J Gen Intern Med       Date:  2003-02       Impact factor: 5.128

9.  Effects of media coverage of Women's Health Initiative study on attitudes and behavior of women receiving hormone replacement therapy.

Authors:  Jennifer McIntosh; Susan J Blalock
Journal:  Am J Health Syst Pharm       Date:  2005-01-01       Impact factor: 2.637

10.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

View more
  4 in total

1.  Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk.

Authors:  Angela Hsu; Andrea Card; Susan Xiaoqin Lin; Sean Mota; Olveen Carrasquillo; Andrew Moran
Journal:  Am J Public Health       Date:  2009-10-15       Impact factor: 9.308

2.  How the Women's Health Initiative (WHI) influenced physicians' practice and attitudes.

Authors:  Terry M Bush; Amy E Bonomi; Larissa Nekhlyudov; Evette J Ludman; Susan D Reed; Maureen T Connelly; Lou C Grothaus; Andrea Z LaCroix; Katherine M Newton
Journal:  J Gen Intern Med       Date:  2007-07-18       Impact factor: 5.128

3.  Average household exposure to newspaper coverage about the harmful effects of hormone therapy and population-based declines in hormone therapy use.

Authors:  Jennifer S Haas; Diana L Miglioretti; Berta Geller; Diana S M Buist; David E Nelson; Karla Kerlikowske; Patricia A Carney; Sarah Dash; Erica S Breslau; Rachel Ballard-Barbash
Journal:  J Gen Intern Med       Date:  2007-01       Impact factor: 5.128

4.  Sources of information influencing the state-of-the-science gap in hormone replacement therapy usage.

Authors:  Fiona Chew; Xianwei Wu
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.